HC Wainwright & Co. Reiterates Buy on Tyra Biosciences, Maintains $19 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Mitchell Kapoor has reiterated a Buy rating on Tyra Biosciences (NASDAQ:TYRA) and maintained a $19 price target on the company's stock.
December 26, 2023 | 11:20 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. analyst Mitchell Kapoor has reiterated a Buy rating on Tyra Biosciences and maintained a $19 price target.
The reiteration of a Buy rating and maintenance of a $19 price target by a reputable analyst could lead to increased investor confidence and a potential short-term positive impact on TYRA's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100